New Drug Safety Bill Introduced Into Congress

By Rheingold Giuffra Ruffo & Plotkin LLP

The Drug Safety Enhancement Act, recently introduced by congressional Democrats would give increased funding and regulatory authority to the FDA in order to promote drug safety in light of the recent recalls involving a variety of drugs, but namely tainted Heparin from China. The bill would create a better registry for foregin facilities that manufacture drugs for the US, generate funding for more Good Manufacturing Practice inspections, as well as a number of other measured directed at making drugs safer in the United States.

FDA’s Current Regulatory Ability

Currently there is minimal regulatory authority and ability for the FDA to regulate facilities overseas. This bill would change that, allowing the FDA to deny entry of drugs into the United States that fail to allow inspectors into their facilities, and that fail safety inspections.

The bill would also grant the FDA the authority to issue a mandatory recall of drugs.

If you have been injured by a defective drugcontact an attorney at Rheingold, Giuffra, Ruffo & Plotkin LLP for a free consultation with an experienced drug injury attorney in the New York area.

Related Posts

What Is Autism?

Recent studies show that Tylenol is related to autism diagnosis in adolescents. These studies have brought about new litigation involving Tylenol and acetaminophen and its alleged effects

View Article